Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;80(4):380-390.
doi: 10.1055/a-1134-5951. Epub 2020 Mar 26.

SARS-CoV-2 Infection in Pregnancy - A Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome

Free PMC article

SARS-CoV-2 Infection in Pregnancy - A Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome

Florian M Stumpfe et al. Geburtshilfe Frauenheilkd. .
Free PMC article


In December 2019, cases of pneumonia of unknown cause first started to appear in Wuhan in China; subsequently, a new coronavirus was soon identified as the cause of the illness, now known as Coronavirus Disease 2019 (COVID-19). Since then, infections have been confirmed worldwide in numerous countries, with the number of cases steadily rising. The aim of the present review is to provide an overview of the new severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) and, in particular, to deduce from it potential risks and complications for pregnant patients. For this purpose, the available literature on cases of infection in pregnancy during the SARS epidemic of 2002/2003, the MERS (Middle East respiratory syndrome) epidemic ongoing since 2012, as well as recent publications on cases infected with SARS-CoV-2 in pregnancy are reviewed and reported. Based on the literature available at the moment, it can be assumed that the clinical course of COVID-19 disease may be complicated by pregnancy which could be associated with a higher mortality rate. It may also be assumed at the moment that transmission from mother to child in utero is unlikely. Breastfeeding is possible once infection has been excluded or the disease declared cured.

Keywords: 2019-nCoV; COVID-19; SARS-CoV-2; coronavirus; pregnancy.

Conflict of interest statement

Conflict of Interest/Interessenkonflikt The authors declare that they have no conflict of interest./Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht.


Fig. 1
Fig. 1
Important milestones of the infections with SARS-CoV-2 since December 2019.
Abb. 1
Abb. 1
Wichtige Meilensteine der Infektionen mit SARS-CoV-2 seit Dezember 2019.

Similar articles

See all similar articles


    1. Hui D S. Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome) Clin Chest Med. 2017;38:71–86. - PMC - PubMed
    1. Report It Coronaviridae. 2011Online: access: 04.03.2020
    1. Li Q, Guan X, Wu P. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 doi: 10.1056/NEJMoa2001316. - DOI - PMC - PubMed
    1. Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30120-1. - DOI - PMC - PubMed